Frits Thorsen

Professor

University of Bergen

Norway

Research Interests

Explore related searches

Professors in Norway Professors in Cancer Biology Cancer Biology professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Frits Thorsen is a Professor at the University of Bergen, Norway. His research areas encompass melanoma and glioblastoma, focusing on innovative therapies and the molecular mechanisms of brain metastases. Recent contributions include investigations into neuroleptic repurposing for melanoma therapy and the role of immune-related genes in glioblastoma development.

Articles (8)

Year:

2025

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Heidi Espedal

University of Western Australia

AUSTRALIA

View details

Synnøve Nymark Aasen

Associate Professor

Western Norway University of Applied Sciences

NORWAY

View details

Amos Bairoch

Professor

University of Geneva

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Frits Thorsen

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Repurposing neuroleptics: clozapine as a novel, adjuvant therapy for melanoma brain metastases

CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells

Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis

Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.

Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines.

Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.

Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.

Collaborators (3)

Heidi Espedal

Synnøve Nymark Aasen

Amos Bairoch

Make your next move.